2015
DOI: 10.1002/glia.22893
|View full text |Cite
|
Sign up to set email alerts
|

Elevated GFAP induces astrocyte dysfunction in caudal brain regions: A potential mechanism for hindbrain involved symptoms in type II Alexander disease

Abstract: Alexander Disease (AxD) is a ‘gliopathy’ caused by toxic, dominant gain-of-function mutations in the glial fibrillary acidic protein (GFAP) gene. Two distinct types of AxD exist. Type I AxD affected individuals develop cerebral symptoms by four years of age and suffer from macrocephaly, seizures, and physical and mental delays. As detection and diagnosis have improved, approximately half of all AxD patients diagnosed have onset >4 years and brainstem/spinal cord involvement. Type II AxD patients experience ata… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
20
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 27 publications
(25 citation statements)
references
References 65 publications
5
20
0
Order By: Relevance
“…These data are in line with previous results [17] that TG mice reveal more severe pathology compared to KI mice.…”
Section: Resultssupporting
confidence: 93%
“…These data are in line with previous results [17] that TG mice reveal more severe pathology compared to KI mice.…”
Section: Resultssupporting
confidence: 93%
“…In whole-cell voltage clamp recording with a K + -based solution, astrocytes exhibited a characteristic linear current-voltage (I-V) relationship membrane K + conductance or passive conductance ( Figure 2C,D). This current profile was consistent with the findings of other studies that focused on spinal grey matter [19,20]. Furthermore, these astrocytes exhibit a relatively negative resting membrane potential of −80.8 ± 3.7 mV (n = 9) and a low input membrane resistance (Rin) of 21.1 ± 7.0 MΩ (n = 5).…”
Section: Electrophysiological Properties Of Grey Matter Astrocytes Insupporting
confidence: 91%
“…The neurological abnormalities and early death of AxD can be recapitulated in mice and flies by overexpression not only of mutant forms of GFAP but also of normal GFAP [18, 4547]. In AxD, a reduction in the level of the GLT1 glutamate transporter in vulnerable brain regions has been suggested to affect glutamate clearance leading to excitotoxic death of neurons [4850]. Similarly, in MeCP2-Tg mice, the increased expression of GFAP and reduction in GLAST is most pronounced in the MeCP2-Tg cortex and hippocampus, where neuronal loss occurs subsequently.…”
Section: Discussionmentioning
confidence: 99%